The Journal of Heart and Lung Transplantation
Volume 29, Issue 5 , Pages 554-561 , May 2010

Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart

  • Monique L. Ogletree, PhD

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Wendy E. Sweet, MS

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Cassandra Talerico, PhD

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Mary E. Klecka, BA

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • James B. Young, MD

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Nicholas G. Smedira, MD

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Randall C. Starling, MD, MPH

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Christine S. Moravec, PhD

      Affiliations

    • Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio
    • Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationReprint requests: Christine S. Moravec, PhD, Department of Cardiovascular Medicine, NE61, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. Telephone: 216-445-9949. Fax: 216-445-9951

References 

  1. Gwathmey JK, Copelas L, Mackinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70–76
  2. Hasenfuss G, Mulieri LA, Leavitt BJ, et al. Alterations of contractile function and excitation contraction coupling in dilated cardiomyopathy. Circ Res. 1992;70:1225–1232
  3. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205–211
  4. Pieske B, Sutterlin M, Schmidt-Schweda S, et al. Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy (Functional evidence for alterations in intracellular Ca2+ handling). J Clin Invest. 1996;98:764–776
  5. Burkhoff D, Klotz S, Mancini DM. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail. 2006;12:227–239
  6. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675–682
  7. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation. 2007;115:2497–2505
  8. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92:II-191-5
  9. Goldstein DJ, Moazami N, Seldomridge JA, et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg. 1997;63:971–974
  10. Zafeiridis A, Jeevanandam V, Houser SR, et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;98:656–662
  11. McCarthy PM, Nakatani S, Vargo R, et al. Structural and left ventricular histological changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609–613
  12. Aquila LA, McCarthy PM, Smedira NG, et al. Cytoskeletal structure and recovery in single human cardiac myocytes. J Heart Lung Transplant. 2004;23:954–963
  13. Altemose GT, Gritsus V, Jeevanandam V, et al. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997;16:765–773
  14. Xydas S, Rosen RS, Ng C, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant. 2006;25:7–15
  15. Lowes BD, Zolty R, Shakar SF, et al. Assist devices fail to reverse patterns of fetal gene expression despite β-blockers. J Heart Lung Transplant. 2007;26:1170–1176
  16. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316–2322
  17. Ogletree-Hughes ML, Stull LB, et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation. 2001;104:881–886
  18. Muller J, Wallukat G, Weng Y-G, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542–549
  19. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383–2389
  20. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873–1884
  21. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  22. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505
  23. Dandel M, Weng Y, Siniawski H, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation. 2008;118(suppl 1):S94–S105
  24. Mano A, Naktatani T, Oda N, et al. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system?. J Heart Lung Transplant. 2008;27:869–874
  25. Latif N, Yacoub MH, George R, et al. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung Transplant. 2007;26:230–235
  26. Gwathmey JK, Slawsky MT, Hajjar RJ, et al. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 1990;85:1599–1613
  27. Pieske B, Kretschmann B, Meyer M, et al. Alterations in intracellular calcium handling associated with the inverse force–frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169–1178
  28. Hajjar RJ, Zsebo K, Deckelbaum L, et al. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail. 2008;14:355–367
  29. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713–2719
  30. Rodrigue-Way A, Burkoff D, Geesaman BJ, et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant. 2005;24:73–80
  31. Barbone A, Holmes JW, Heerdt PM, et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure (A primary role of mechanical unloading underlying reverse remodeling). Circulation. 2001;104:670–675
  32. Chaudhary KW, Rossman EI, Paicentino V, et al. Altered myocardial Ca2+ cycling after left ventricular device support in the failing human heart. J Am Coll Cardiol. 2004;44:837–845
  33. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. 2001;121:902–908
  34. Moravec CS, Schluchter MD, Paranandi L, et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 1990;82:1973–1984
  35. DiPaola NR, Sweet WE, Stull LB, et al. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied, and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol. 2001;33:1283–1295
  36. Koss KL, Grupp IL, Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Bas Res Cardiol. 1997;92:17–24
  37. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743–1750
  38. Hasenfuss G, Reinecke H, Studer R, et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and non-failing human myocardium. Circ Res. 1994;75:434–442
  39. Davies CH, Davia K, Bennett JG, et al. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 1995;92:2540–2549
  40. Westaby S, Jin XY, Katsumata T, et al. Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery. Ann Thorac Surg. 1997;64:1301–1308
  41. Takeishi Y, Jalili T, Hoit BD, et al. Alterations in Ca2+ cycling proteins and Gαq signaling after left ventricular device support in failing human hearts. Cardiovasc Res. 2000;45:883–888
  42. Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008;51:1784–1789
  43. Vanderheyden M, Mullens W, del Rue L, et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol. 2008;51:129–136
  44. Flesch M, Schwinger RH, Schiffer F, et al. Evidence for functional relevance of an enhanced expression of the Na+–Ca2+ exchanger in failing human myocardium. Circulation. 1996;94:992–1002
  45. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–376
  46. Maybaum S, Epstein S, Beniaminovitz A, et al. Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism, and increased exercise capacity. J Heart Lung Transplant. 2002;21:446–454

 Current affiliation for M.L.O: Department of Molecular Physiology and Biophysics, University of Houston, Houston, Texas.

PII: S1053-2498(09)00848-1

doi: 10.1016/j.healun.2009.10.015

The Journal of Heart and Lung Transplantation
Volume 29, Issue 5 , Pages 554-561 , May 2010

Article Tools

* Image Usage & Resolution